Since the initial identification of the S59L substitution in CHCHD10, additional variants have been identified and suggested as pathogenic mediators of ALS-FTD, SMAJ, and mitochondrial myopathy. This evidence concerns the gene CHCHD10 and frontotemporal dementia.